Skip to main content
Erschienen in: Surgical Endoscopy 10/2016

29.12.2015

Laparoscopic hepatectomy versus radiofrequency ablation for minimally invasive treatment of single, small hepatocellular carcinomas

verfasst von: Juxian Song, Yu Wang, Kuansheng Ma, Shuguo Zheng, Ping Bie, Feng Xia, Xiaowu Li, Jianwei Li, Xiaojun Wang, Jian Chen

Erschienen in: Surgical Endoscopy | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

There is currently no clear consensus on the relative suitabilities of laparoscopic hepatectomy (LH) and radiofrequency ablation (RFA) as minimally invasive treatment for small hepatocellular carcinoma (HCC).

Methods

In this retrospective study, we enrolled 156 patients with a single, small HCC with nodular diameters <4 cm and compared recurrence-free survival (RFS) and overall survival (OS) between patients treated with LH and control patients treated with RFA (n = 78 each). The groups were selected according to predefined criteria and matched in terms of their baseline clinical characteristics.

Results

During a median follow-up of 31.2 months, the 1-, 2-, and 3-year OS rates in the LH group were 96.2, 91.3, and 84.1 %, respectively, compared with 96.2, 82.6, and 78.8 % in the RFA group. The corresponding RFS rates were 82.1, 71.5, and 60.0 % in the LH group and 65.4, 47.7, and 37.6 % in the RFA group. Combined RFS rates were significantly higher in the LH groups (P = 0.006), but there was no significant difference in OS rates (P = 0.510). The incidence of postoperative complications was significantly lower in the RFA group (28.2 vs. 10.3 %, P = 0.004), and operation duration, intraoperative blood loss and blood transfusion, use of total parenteral nutrition, and length of stay as indicators of minimal invasiveness were also significantly better in the RFA group.

Conclusions

There was no difference between LH and RFA in terms of OS in patients with a single, small HCC. However, RFA was less invasive than the LH, but LH was associated with increased RFS.
Literatur
1.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed
2.
Zurück zum Zitat Bruix J, Sherman M, Practice Guidelines Committee AAftSoLD (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236CrossRefPubMed Bruix J, Sherman M, Practice Guidelines Committee AAftSoLD (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236CrossRefPubMed
3.
Zurück zum Zitat Bruix J, Llovet JM (2009) Major achievements in hepatocellular carcinoma. Lancet 373:614–616CrossRefPubMed Bruix J, Llovet JM (2009) Major achievements in hepatocellular carcinoma. Lancet 373:614–616CrossRefPubMed
4.
Zurück zum Zitat Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D’Angelica MI, Blumgart LH, Dematteo RP (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249:617–623CrossRefPubMed Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D’Angelica MI, Blumgart LH, Dematteo RP (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249:617–623CrossRefPubMed
5.
Zurück zum Zitat Conrad C, Ogiso S, Inoue Y, Shivathirthan N, Gayet B (2015) Laparoscopic parenchymal-sparing liver resection of lesions in the central segments: feasible, safe, and effective. Surg Endosc 29:2410–2417CrossRefPubMed Conrad C, Ogiso S, Inoue Y, Shivathirthan N, Gayet B (2015) Laparoscopic parenchymal-sparing liver resection of lesions in the central segments: feasible, safe, and effective. Surg Endosc 29:2410–2417CrossRefPubMed
6.
Zurück zum Zitat Ishizawa T, Gumbs AA, Kokudo N, Gayet B (2012) Laparoscopic segmentectomy of the liver: from segment I to VIII. Ann Surg 256:959–964CrossRefPubMed Ishizawa T, Gumbs AA, Kokudo N, Gayet B (2012) Laparoscopic segmentectomy of the liver: from segment I to VIII. Ann Surg 256:959–964CrossRefPubMed
7.
Zurück zum Zitat Hirokawa F, Hayashi M, Miyamoto Y, Asakuma M, Shimizu T, Komeda K, Inoue Y, Uchiyama K (2015) Short- and long-term outcomes of laparoscopic versus open hepatectomy for small malignant liver tumors: a single-center experience. Surg Endosc 29:458–465CrossRefPubMed Hirokawa F, Hayashi M, Miyamoto Y, Asakuma M, Shimizu T, Komeda K, Inoue Y, Uchiyama K (2015) Short- and long-term outcomes of laparoscopic versus open hepatectomy for small malignant liver tumors: a single-center experience. Surg Endosc 29:458–465CrossRefPubMed
8.
Zurück zum Zitat Vibert E, Perniceni T, Levard H, Denet C, Shahri NK, Gayet B (2006) Laparoscopic liver resection. Br J Surg 93:67–72CrossRefPubMed Vibert E, Perniceni T, Levard H, Denet C, Shahri NK, Gayet B (2006) Laparoscopic liver resection. Br J Surg 93:67–72CrossRefPubMed
9.
Zurück zum Zitat Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Gwak GY, Yoo BC (2013) Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 58:89–97CrossRefPubMed Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Gwak GY, Yoo BC (2013) Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 58:89–97CrossRefPubMed
10.
Zurück zum Zitat Ng KK, Poon RT, Lam CM, Yuen J, Tso WK, Fan ST (2006) Efficacy and safety of radiofrequency ablation for perivascular hepatocellular carcinoma without hepatic inflow occlusion. Br J Surg 93:440–447CrossRefPubMed Ng KK, Poon RT, Lam CM, Yuen J, Tso WK, Fan ST (2006) Efficacy and safety of radiofrequency ablation for perivascular hepatocellular carcinoma without hepatic inflow occlusion. Br J Surg 93:440–447CrossRefPubMed
11.
Zurück zum Zitat Poon RT, Fan ST, Tsang FH, Wong J (2002) Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg 235:466–486CrossRefPubMedPubMedCentral Poon RT, Fan ST, Tsang FH, Wong J (2002) Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg 235:466–486CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Forner A, Bruix J (2012) Biomarkers for early diagnosis of hepatocellular carcinoma. Lancet Oncol 13:750–751CrossRefPubMed Forner A, Bruix J (2012) Biomarkers for early diagnosis of hepatocellular carcinoma. Lancet Oncol 13:750–751CrossRefPubMed
13.
Zurück zum Zitat Papatheodoridis GV, Chan HL, Hansen BE, Janssen HL, Lampertico P (2015) Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol 62:956–967CrossRefPubMed Papatheodoridis GV, Chan HL, Hansen BE, Janssen HL, Lampertico P (2015) Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol 62:956–967CrossRefPubMed
14.
Zurück zum Zitat Pearce NW, Di Fabio F, Abu Hilal M (2011) Laparoscopic left hepatectomy with extraparenchymal inflow control. J Am Coll Surg 213:e23–e27CrossRefPubMed Pearce NW, Di Fabio F, Abu Hilal M (2011) Laparoscopic left hepatectomy with extraparenchymal inflow control. J Am Coll Surg 213:e23–e27CrossRefPubMed
15.
Zurück zum Zitat Cheung TT, Poon RT, Yuen WK, Chok KS, Jenkins CR, Chan SC, Fan ST, Lo CM (2013) Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg 257:506–511CrossRefPubMed Cheung TT, Poon RT, Yuen WK, Chok KS, Jenkins CR, Chan SC, Fan ST, Lo CM (2013) Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg 257:506–511CrossRefPubMed
16.
Zurück zum Zitat Feng K, Yan J, Li X, Xia F, Ma K, Wang S, Bie P, Dong J (2012) A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 57:794–802CrossRefPubMed Feng K, Yan J, Li X, Xia F, Ma K, Wang S, Bie P, Dong J (2012) A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 57:794–802CrossRefPubMed
17.
Zurück zum Zitat Villanueva A, Hernandez-Gea V, Llovet JM (2013) Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nat Rev Gastroenterol Hepatol 10:34–42CrossRefPubMed Villanueva A, Hernandez-Gea V, Llovet JM (2013) Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nat Rev Gastroenterol Hepatol 10:34–42CrossRefPubMed
18.
Zurück zum Zitat Karabulut K, Aucejo F, Akyildiz HY, Siperstein A, Berber E (2012) Resection and radiofrequency ablation in the treatment of hepatocellular carcinoma: a single-center experience. Surg Endosc 26:990–997CrossRefPubMed Karabulut K, Aucejo F, Akyildiz HY, Siperstein A, Berber E (2012) Resection and radiofrequency ablation in the treatment of hepatocellular carcinoma: a single-center experience. Surg Endosc 26:990–997CrossRefPubMed
19.
Zurück zum Zitat Tiong L, Maddern GJ (2011) Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 98:1210–1224CrossRefPubMed Tiong L, Maddern GJ (2011) Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 98:1210–1224CrossRefPubMed
20.
Zurück zum Zitat Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y (2010) A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 252:903–912CrossRefPubMed Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y (2010) A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 252:903–912CrossRefPubMed
21.
Zurück zum Zitat Minami Y, Kawasaki T, Kudo M, Haji S, Shiraishi O, Kawabe T, Yasuda C, Nakai T, Takeyama Y, Shiozaki H (2007) Treatment of large and/or multiple hepatic malignancies: open surgical approaches of radiofrequency ablation. Hepato-gastroenterology 54:2358–2360PubMed Minami Y, Kawasaki T, Kudo M, Haji S, Shiraishi O, Kawabe T, Yasuda C, Nakai T, Takeyama Y, Shiozaki H (2007) Treatment of large and/or multiple hepatic malignancies: open surgical approaches of radiofrequency ablation. Hepato-gastroenterology 54:2358–2360PubMed
22.
Zurück zum Zitat Golfieri R, Bilbao JI, Carpanese L, Cianni R, Gasparini D, Ezziddin S, Paprottka PM, Fiore F, Cappelli A, Rodriguez M, Ettorre GM, Saltarelli A, Geatti O, Ahmadzadehfar H, Haug AR, Izzo F, Giampalma E, Sangro B, Pizzi G, Notarianni E, Vit A, Wilhelm K, Jakobs TF, Lastoria S, European Network on Radioembolization with Yttrium-90 Microspheres study c (2013) Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. J Hepatol 59:753–761CrossRefPubMed Golfieri R, Bilbao JI, Carpanese L, Cianni R, Gasparini D, Ezziddin S, Paprottka PM, Fiore F, Cappelli A, Rodriguez M, Ettorre GM, Saltarelli A, Geatti O, Ahmadzadehfar H, Haug AR, Izzo F, Giampalma E, Sangro B, Pizzi G, Notarianni E, Vit A, Wilhelm K, Jakobs TF, Lastoria S, European Network on Radioembolization with Yttrium-90 Microspheres study c (2013) Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. J Hepatol 59:753–761CrossRefPubMed
23.
Zurück zum Zitat Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O, Matsuyama Y (2013) Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol 58:724–729CrossRefPubMed Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O, Matsuyama Y (2013) Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol 58:724–729CrossRefPubMed
24.
Zurück zum Zitat Pompili M, Saviano A, de Matthaeis N, Cucchetti A, Ardito F, Federico B, Brunello F, Pinna AD, Giorgio A, Giulini SM, De Sio I, Torzilli G, Fornari F, Capussotti L, Guglielmi A, Piscaglia F, Aldrighetti L, Caturelli E, Calise F, Nuzzo G, Rapaccini GL, Giuliante F (2013) Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey. J Hepatol 59:89–97CrossRefPubMed Pompili M, Saviano A, de Matthaeis N, Cucchetti A, Ardito F, Federico B, Brunello F, Pinna AD, Giorgio A, Giulini SM, De Sio I, Torzilli G, Fornari F, Capussotti L, Guglielmi A, Piscaglia F, Aldrighetti L, Caturelli E, Calise F, Nuzzo G, Rapaccini GL, Giuliante F (2013) Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey. J Hepatol 59:89–97CrossRefPubMed
25.
Zurück zum Zitat Xu Q, Kobayashi S, Ye X, Meng X (2014) Comparison of hepatic resection and radiofrequency ablation for small hepatocellular carcinoma: a meta-analysis of 16,103 patients. Sci Rep 4:7252CrossRefPubMedPubMedCentral Xu Q, Kobayashi S, Ye X, Meng X (2014) Comparison of hepatic resection and radiofrequency ablation for small hepatocellular carcinoma: a meta-analysis of 16,103 patients. Sci Rep 4:7252CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Parisi A, Desiderio J, Trastulli S, Castellani E, Pasquale R, Cirocchi R, Boselli C, Noya G (2013) Liver resection versus radiofrequency ablation in the treatment of cirrhotic patients with hepatocellular carcinoma. Hepatob Pancreat Dis Int 12:270–277CrossRef Parisi A, Desiderio J, Trastulli S, Castellani E, Pasquale R, Cirocchi R, Boselli C, Noya G (2013) Liver resection versus radiofrequency ablation in the treatment of cirrhotic patients with hepatocellular carcinoma. Hepatob Pancreat Dis Int 12:270–277CrossRef
27.
Zurück zum Zitat Long TCD, Bac NH, Thuan ND, Dat LT, Viet DQ, Chuong LCHQ (2014) Laparoscopic liver resection: 5-year experience at a single center. Surg Endosc Other Interv Tech 28:796–802CrossRef Long TCD, Bac NH, Thuan ND, Dat LT, Viet DQ, Chuong LCHQ (2014) Laparoscopic liver resection: 5-year experience at a single center. Surg Endosc Other Interv Tech 28:796–802CrossRef
28.
Zurück zum Zitat Chen K, Chen G, Wang H, Li H, Xiao J, Duan X, He J, He K, Xiang G (2014) Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial. J Hepatol 61:1304–1311CrossRefPubMed Chen K, Chen G, Wang H, Li H, Xiao J, Duan X, He J, He K, Xiang G (2014) Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial. J Hepatol 61:1304–1311CrossRefPubMed
29.
Zurück zum Zitat Feng X, Xu R, Du X, Dou K, Qin X, Xu J, Jia W, Wang Z, Zhao H, Yang S, Guo C, Liu T, Ma K (2014) Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study. Am J Gastroenterol 109:1891–1899CrossRefPubMed Feng X, Xu R, Du X, Dou K, Qin X, Xu J, Jia W, Wang Z, Zhao H, Yang S, Guo C, Liu T, Ma K (2014) Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study. Am J Gastroenterol 109:1891–1899CrossRefPubMed
30.
Zurück zum Zitat Knab LM, Salem R, Mahvi DM (2013) Minimally invasive therapies for hepatic malignancy. Curr Probl Surg 50:146–179CrossRefPubMed Knab LM, Salem R, Mahvi DM (2013) Minimally invasive therapies for hepatic malignancy. Curr Probl Surg 50:146–179CrossRefPubMed
31.
Zurück zum Zitat Lurje G, Lesurtel M, Clavien PA (2013) Multimodal treatment strategies in patients undergoing surgery for hepatocellular carcinoma. Dig Dis 31:112–117CrossRefPubMed Lurje G, Lesurtel M, Clavien PA (2013) Multimodal treatment strategies in patients undergoing surgery for hepatocellular carcinoma. Dig Dis 31:112–117CrossRefPubMed
Metadaten
Titel
Laparoscopic hepatectomy versus radiofrequency ablation for minimally invasive treatment of single, small hepatocellular carcinomas
verfasst von
Juxian Song
Yu Wang
Kuansheng Ma
Shuguo Zheng
Ping Bie
Feng Xia
Xiaowu Li
Jianwei Li
Xiaojun Wang
Jian Chen
Publikationsdatum
29.12.2015
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 10/2016
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-015-4737-1

Weitere Artikel der Ausgabe 10/2016

Surgical Endoscopy 10/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.